modern pharma limited
modern pharma limited Company Information
Company Number
03920939
Website
https://modernpharmaye.comRegistered Address
fifth floor watson house, 54-60 baker street, london, W1U 7BU
Industry
Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
Activities of head offices
Telephone
-
Next Accounts Due
May 2024
Group Structure
View All
Shareholders
dilip khetshi lakhamshi maroo 60%
orion holdings (uk) limited 30%
View Allmodern pharma limited Estimated Valuation
Pomanda estimates the enterprise value of MODERN PHARMA LIMITED at £696.8k based on a Turnover of £340.4k and 2.05x industry multiple (adjusted for size and gross margin).
modern pharma limited Estimated Valuation
Pomanda estimates the enterprise value of MODERN PHARMA LIMITED at £536.3k based on an EBITDA of £111.4k and a 4.81x industry multiple (adjusted for size and gross margin).
modern pharma limited Estimated Valuation
Pomanda estimates the enterprise value of MODERN PHARMA LIMITED at £1.7m based on Net Assets of £595.4k and 2.83x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Modern Pharma Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Modern Pharma Limited Overview
Modern Pharma Limited is a live company located in london, W1U 7BU with a Companies House number of 03920939. It operates in the activities of other holding companies n.e.c. sector, SIC Code 64209. Founded in February 2000, it's largest shareholder is dilip khetshi lakhamshi maroo with a 60% stake. Modern Pharma Limited is a mature, micro sized company, Pomanda has estimated its turnover at £340.4k with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Modern Pharma Limited Health Check
Pomanda's financial health check has awarded Modern Pharma Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 4 areas for improvement. Company Health Check FAQs
1 Strong
3 Regular
4 Weak
Size
annual sales of £340.4k, make it smaller than the average company (£17.9m)
- Modern Pharma Limited
£17.9m - Industry AVG
Growth
3 year (CAGR) sales growth of 3%, show it is growing at a slower rate (3.6%)
- Modern Pharma Limited
3.6% - Industry AVG
Production
with a gross margin of 34%, this company has a comparable cost of product (34%)
- Modern Pharma Limited
34% - Industry AVG
Profitability
an operating margin of 32.7% make it more profitable than the average company (5.9%)
- Modern Pharma Limited
5.9% - Industry AVG
Employees
with 2 employees, this is below the industry average (111)
2 - Modern Pharma Limited
111 - Industry AVG
Pay Structure
on an average salary of £41.3k, the company has an equivalent pay structure (£41.3k)
- Modern Pharma Limited
£41.3k - Industry AVG
Efficiency
resulting in sales per employee of £170.2k, this is equally as efficient (£170.2k)
- Modern Pharma Limited
£170.2k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Modern Pharma Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Modern Pharma Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Modern Pharma Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Modern Pharma Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 71.9%, this is a higher level of debt than the average (63.5%)
71.9% - Modern Pharma Limited
63.5% - Industry AVG
modern pharma limited Credit Report and Business Information
Modern Pharma Limited Competitor Analysis
Perform a competitor analysis for modern pharma limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
modern pharma limited Ownership
MODERN PHARMA LIMITED group structure
Modern Pharma Limited has 1 subsidiary company.
Ultimate parent company
MODERN PHARMA LIMITED
03920939
1 subsidiary
modern pharma limited directors
Modern Pharma Limited currently has 3 directors. The longest serving directors include Mr Hatul Shah (Dec 2006) and Mr Dilip Maroo (Dec 2006).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Hatul Shah | United Kingdom | 45 years | Dec 2006 | - | Director |
| Mr Dilip Maroo | 64 years | Dec 2006 | - | Director | |
| Mr Rishie Harania | United Kingdom | 45 years | May 2010 | - | Director |
MODERN PHARMA LIMITED financials
Modern Pharma Limited's latest turnover from August 2022 is estimated at £340.4 thousand and the company has net assets of £595.4 thousand. According to their latest financial statements, Modern Pharma Limited has 2 employees and maintains cash reserves of £56 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | Aug 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||||||||
| Other Income Or Grants | ||||||||||||||
| Cost Of Sales | ||||||||||||||
| Gross Profit | ||||||||||||||
| Admin Expenses | ||||||||||||||
| Operating Profit | ||||||||||||||
| Interest Payable | ||||||||||||||
| Interest Receivable | ||||||||||||||
| Pre-Tax Profit | ||||||||||||||
| Tax | ||||||||||||||
| Profit After Tax | ||||||||||||||
| Dividends Paid | ||||||||||||||
| Retained Profit | ||||||||||||||
| Employee Costs | ||||||||||||||
| Number Of Employees | 2 | 2 | 2 | 2 | 2 | |||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | Aug 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 1,839,470 | 1,839,470 | 1,839,470 | 1,839,470 | 1,839,470 | 1,839,470 | 1,839,470 | 1,839,470 | 1,839,470 | 1,839,470 | 1,839,470 | 1,839,470 | 1,839,470 | 1,839,470 |
| Debtors (Due After 1 year) | 277,189 | 277,189 | 277,189 | 277,189 | 277,189 | 277,189 | 277,189 | 277,189 | 277,189 | 277,189 | 277,189 | 277,189 | 277,189 | 277,189 |
| Total Fixed Assets | 2,116,659 | 2,116,659 | 2,116,659 | 2,116,659 | 2,116,659 | 2,116,659 | 2,116,659 | 2,116,659 | 2,116,659 | 2,116,659 | 2,116,659 | 2,116,659 | 2,116,659 | 2,116,659 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 553 | 400 | 0 | 0 | 109 | 0 | 47,052 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 180 | 0 | 0 | 400 | 553 | 553 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 56 | 56 | 56 | 91 | 1,192 | 219 | 2,688 | 3,467 | 1,621 | 3,423 | 7,715 | 4,290 | 2,367 | 13,581 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 56 | 236 | 56 | 91 | 1,592 | 772 | 3,241 | 4,020 | 2,021 | 3,423 | 7,715 | 4,399 | 2,367 | 60,633 |
| total assets | 2,116,715 | 2,116,895 | 2,116,715 | 2,116,750 | 2,118,251 | 2,117,431 | 2,119,900 | 2,120,679 | 2,118,680 | 2,120,082 | 2,124,374 | 2,121,058 | 2,119,026 | 2,177,292 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 91,146 | 91,146 | 76,659 | 47,100 | 193,596 | 193,596 | 206,600 | 267,811 | 241,807 |
| Bank loan | 0 | 0 | 0 | 0 | 91,146 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7,267 | 3,171 | 4,425 | 4,370 | 5,286 | 225,191 | 79,698 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 180 | 0 | 0 | 5,946 | 4,146 | 7,605 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 0 | 180 | 0 | 0 | 97,092 | 95,292 | 98,751 | 83,926 | 50,271 | 198,021 | 197,966 | 211,886 | 493,002 | 321,505 |
| loans | 1,439,360 | 1,439,210 | 1,438,940 | 1,438,790 | 1,343,090 | 1,344,434 | 1,343,429 | 488,045 | 557,600 | 523,707 | 707,367 | 875,788 | 1,029,521 | 1,288,851 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 81,923 | 81,923 | 81,923 | 81,923 | 81,923 | 81,923 | 81,923 | 952,905 | 914,981 | 802,518 | 623,205 | 437,291 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 1,521,283 | 1,521,133 | 1,520,863 | 1,520,713 | 1,425,013 | 1,426,357 | 1,425,352 | 1,440,950 | 1,472,581 | 1,326,225 | 1,330,572 | 1,313,079 | 1,029,521 | 1,288,851 |
| total liabilities | 1,521,283 | 1,521,313 | 1,520,863 | 1,520,713 | 1,522,105 | 1,521,649 | 1,524,103 | 1,524,876 | 1,522,852 | 1,524,246 | 1,528,538 | 1,524,965 | 1,522,523 | 1,610,356 |
| net assets | 595,432 | 595,582 | 595,852 | 596,037 | 596,146 | 595,782 | 595,797 | 595,803 | 595,828 | 595,836 | 595,836 | 596,093 | 596,503 | 566,936 |
| total shareholders funds | 595,432 | 595,582 | 595,852 | 596,037 | 596,146 | 595,782 | 595,797 | 595,803 | 595,828 | 595,836 | 595,836 | 596,093 | 596,503 | 566,936 |
| Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | Aug 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | ||||||||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | ||||||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -180 | 180 | 0 | -400 | -153 | 0 | 0 | 153 | 400 | 0 | -109 | 109 | -47,052 | 324,241 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 0 | -7,267 | 4,096 | -1,254 | 55 | -916 | -219,905 | 145,493 | 79,698 |
| Accruals and Deferred Income | -180 | 180 | 0 | -5,946 | 1,800 | -3,459 | 7,605 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||||||||
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,839,470 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | -91,146 | 91,146 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 150 | 270 | 150 | 95,700 | -1,344 | 1,005 | 855,384 | -69,555 | 33,893 | -183,660 | -168,421 | -153,733 | -259,330 | 1,288,851 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | -870,982 | 37,924 | 112,463 | 179,313 | 185,914 | 437,291 | 0 | 0 |
| share issue | ||||||||||||||
| interest | ||||||||||||||
| cash flow from financing | ||||||||||||||
| cash and cash equivalents | ||||||||||||||
| cash | 0 | 0 | -35 | -1,101 | 973 | -2,469 | -779 | 1,846 | -1,802 | -4,292 | 3,425 | 1,923 | -11,214 | 13,581 |
| overdraft | 0 | 0 | 0 | 0 | -91,146 | 0 | 14,487 | 29,559 | -146,496 | 0 | -13,004 | -61,211 | 26,004 | 241,807 |
| change in cash | 0 | 0 | -35 | -1,101 | 92,119 | -2,469 | -15,266 | -27,713 | 144,694 | -4,292 | 16,429 | 63,134 | -37,218 | -228,226 |
P&L
August 2022turnover
340.4k
+13%
operating profit
111.4k
0%
gross margin
34%
+4.9%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
August 2022net assets
595.4k
0%
total assets
2.1m
0%
cash
56
0%
net assets
Total assets minus all liabilities
Similar Companies
modern pharma limited company details
company number
03920939
Type
Private limited with Share Capital
industry
64209 - Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
70100 - Activities of head offices
incorporation date
February 2000
age
24
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
incorporated
UK
address
fifth floor watson house, 54-60 baker street, london, W1U 7BU
last accounts submitted
August 2022
modern pharma limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to modern pharma limited. Currently there are 2 open charges and 1 have been satisfied in the past.
modern pharma limited Companies House Filings - See Documents
| date | description | view/download |
|---|
